Breast Cancer
Conditions
Keywords
Breast Cancer, Advanced Breast Cancer, Epidemiology, Registry, Health Services Research, Germany, Palliative Treatment, Adjuvant Drug Therapy, Nutrition Assessment, Physical Activity
Brief summary
The registry aims to collect and analyse information on the antineoplastic treatment of breast cancer in daily routine practice of office-based and clinic-based medical oncologists in Germany.
Detailed description
The TMK is a prospective, longitudinal, nation wide cohort study with the purpose to record information on the antineoplastic treatment of breast cancer in Germany. The registry will follow patients for up to five years. It will identify common therapeutic sequences and changes in the treatment of the disease. At inclusion, data in patient characteristics, comorbidities, tumor characteristics, biomarker testing and previous treatments are collected. During the course of observation data on all systemic treatments, radiotherapies, surgeries, and outcome are documented. The impact of nutrition (MaNut) and physical activity (MaNut) on the course of the adjuvant disease will be examined, as well as long-term effects of adjuvant treatment (MaTox) and the multiple patient-reported outcomes (MaLife).
Interventions
None listed
Sponsors
Arbeitskreis Klinische Studien
Arbeitsgemeinschaft fur Internistische Onkologie
iOMEDICO AG
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Breast cancer * 18 years and older * Antineoplastic or antihormonal treatment
Exclusion criteria
* No breast cancer * Below 18 years * No antineoplastic or antihormonal treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Course of Antineoplastic Treatment | 5 years |
Outcome results
None listed